Meet Proteona at the BioRN Annual Conference 2020
Innovative AI-driven genomic and proteomic analysis platform for improving cell therapy and immuno-oncology
Proteona will attend the BioRN Annual Conference 2020, taking place on Friday, the 20th of November 2020.
This year’s conference, focusing on the topic of “Precision Technologies 4 Life”, will be delivered virtually. It will feature keynote presentations on using molecular profiling to improve disease detection and precision medicine. Register now to schedule one-to-one meetings with Proteona.
Check out the BioRN 2020 conference program here!
For media queries, please contact:
Dr Andreas Schmidt
Proteona is a precision medicine company in Singapore, Germany, and the US that is pioneering the use of single cell multi-omics to improve clinical outcomes in cancer. Using a combination of innovative single cell assays and AI-assisted bioinformatics, Proteona enables pharmaceutical companies, biotech partners, and clinicians to integrate single cell level precision into their clinical projects. Proteona continues to develop comprehensive, disease-specific single cell databases combining gene expression, protein expression, and mutation information derived from each individual cells as well as drug response data for each sample. Proteona has been selected as a “One to Watch” by Nature Research Spinoff Award and a Winner of Falling Walls Ventures Breakthrough of the Year 2020. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR).